Vios Medical

The Vios Monitoring System is a wireless, FDA-cleared medical device that enables continuous monitoring of vitals.

General Information
Company Name
Vios Medical
Founded Year
2012
Location (Offices)
Woodbury, United States +1
Founders / Decision Makers
Number of Employees
22
Industries
Health Care, IT, Medical Devices
Funding Stage
Series Unknown
Social Media

Vios Medical - Company Profile

Murata Vios is revolutionizing intensive healthcare with its wireless monitoring platform, leveraging IoT sensors and big data solutions to improve outcomes and cost efficiency. The company's Vios Monitoring System (VMS) is FDA-cleared and designed to enhance clinician productivity, reduce hospital expenses, and continuously monitor vital signs, posture, and more. Founded in 2012 and headquartered in Saint Paul, Minnesota, United States, Murata Vios received a $3.98M Venture Round investment on 09 June 2016. The VMS offers an innovative approach to patient management, allowing healthcare facilities to integrate it into their existing IT infrastructures and deploy it across various care settings. With its focus on improving care costs, operational efficiency, and patient outcomes, Murata Vios stands at the forefront of revolutionizing healthcare through advanced technology.

Taxonomy: Medical Technology, IoT Sensors, Remote Monitoring, Intensive Healthcare, Cost Efficiency, Wireless Monitoring, Big Data Solutions, FDA Clearance, Healthcare Innovation, Clinical Workflows, Operational Efficiency, Patient Management, Continuous Monitoring, Data-driven Healthcare

Funding Rounds & Investors of Vios Medical (3)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $3.98M - 09 Jun 2016
Venture Round $1.08M - 13 Apr 2015
Venture Round $1.60M - 20 Jun 2013

Latest News of Vios Medical

View All

No recent news or press coverage available for Vios Medical.

Similar Companies to Vios Medical

View All
Biobeat - Similar company to Vios Medical
Biobeat AI remote patient monitoring platform, measuring 13 vital signs and triggering early clinical intervention